Yahoo Poland Wyszukiwanie w Internecie

Search results

1. ashpublications.org › blood › articleDiagnosis and management of AML in adults: 2022 recommendations...

   ashpublications.org › blood › article

   • Zapisane w pamięci cache

   22 wrz 2022 · The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults are widely recognized among physicians and investigators.

2. ashpublications.org › blood › articleDiagnosis, prognostic factors, and assessment of ALL in adults:...

   ashpublications.org › blood › article

   • Zapisane w pamięci cache

   9 maj 2024 · Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia.

3. pmc.ncbi.nlm.nih.gov › articles › PMC8527825New prognostic factors and scoring system for patients with acute...

   pmc.ncbi.nlm.nih.gov › articles › PMC8527825

   Acute myeloid leukemia (AML) is a malignant disease originating from myeloid hematopoietic stem or progenitor cells. It is characterized by abnormal proliferation of primitive and juvenile myeloid cells in the bone marrow and peripheral blood (1, 2). The clinical manifestations of this disease are anemia, hemorrhage, infection, fever, organ ...

4. ashpublications.org › blood › articleMortality and Prognostic Factors of Adult Patients with Acute...

   ashpublications.org › blood › article

   • Zapisane w pamięci cache

   2 lis 2023 · Improved overall survival (OS) has been observed in the past decades in both diseases, but high mortality in the Intensive Care Unit (ICU) persists, which may prevent ICU admission of those patients. We aimed to review the literature on mortality data and survival predictors of patients with acute leukemia (AL) admitted to the ICU.

5. pubmed.ncbi.nlm.nih.gov › 35797463Diagnosis and management of AML in adults: 2022 ... - PubMed

   pubmed.ncbi.nlm.nih.gov › 35797463

   22 wrz 2022 · The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults are widely recognized among physicians and investigators.

6. www.cancerresearchuk.org › about-cancer › acute-myeloid-leukaemia-amlSurvival for acute myeloid leukaemia (AML) - Cancer Research UK

   www.cancerresearchuk.org › about-cancer › acute-myeloid-leukaemia-aml

   • Zapisane w pamięci cache

   more than 15 out of 100 people (more than 15%) will survive their leukaemia for 5 years or more after being diagnosed. This is for all ages. Younger people tend to do better than older people. For those younger than 40: almost 60 out of 100 (almost 60%) will survive their leukaemia for 5 years or more after diagnosis.

7. www.uptodate.com › contents › acute-myeloid-leukemia-in-adults-overviewAcute myeloid leukemia in adults: Overview - UpToDate

   www.uptodate.com › contents › acute-myeloid-leukemia-in-adults-overview

   • Zapisane w pamięci cache

   20 sie 2024 · Acute myeloid leukemia (AML) comprises a heterogeneous group of aggressive blood cell cancers that arise from clonal expansion of malignant hematopoietic precursor cells in the bone marrow. The leukemic cells interfere with production of normal blood cells, causing weakness, infection, bleeding, and other symptoms and complications.